Aro Biotherapeutics Co — Form D

Aro Biotherapeutics Co of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-28. The offering totals $100.0M, of which $24.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2022-12-28
• Form: D
• Accession: 0001878646-22-000058
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $100.0M
• Amount sold: $24.0M
• Remaining: $76.0M
• Investors: 12
• Date of first sale: 2022-12-13
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-468913

Issuer

• Name: Aro Biotherapeutics Co
• CIK: 0001773305
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 3675 MARKET STREET, SUITE 200 3675 Market Street, Suite 200, PHILADELPHIA, PA, 19104
• Phone: 215-544-1175

Officers, directors & promoters (23)

Other filings by this issuer (6)

More

• CIK 1773305 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search